Cargando…

Reactivation of Chagas-Mazza disease during treatment with infliximab

Detalles Bibliográficos
Autores principales:	Vacas, Aldana Soledad, Gomez-Santana, Leidy Viviana, Torre, Ana Clara, Galimberti, Ricardo Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2017
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786422/ http://dx.doi.org/10.1590/abd1806-4841.20177346

Ejemplares similares

The role of interleukin-1β in pyoderma gangrenosum
por: Galimberti, Ricardo Luis, et al.
Publicado: (2016)

Bullous pyoderma gangrenosum as a predictor of hematological malignancies
por: Vacas, Aldana Soledad, et al.
Publicado: (2018)

Authors’ Reply to Mazza et al.: “Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence”
por: Lenze, Eric J., et al.
Publicado: (2022)

Chagas disease reactivation: cutaneous manifestations in a transplanted patient
por: Ferraresso, Maria Guillermina, et al.
Publicado: (2018)

Reactivation of Bovine Tuberculosis in Patient Treated with Infliximab, Switzerland
por: Nager, Marina, et al.
Publicado: (2009)

Medical resource consumption of moderate/severe psoriasis in a private health organization of Buenos Aires, Argentina()()
por: Galimberti, María Laura, et al.
Publicado: (2020)

Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
por: Fernández-Guerrero, Manuel L., et al.
Publicado: (2007)

Comprehensive care for patients with Chagas cardiomyopathy during the coronavirus disease pandemic
por: Mazzoli-Rocha, Flavia, et al.
Publicado: (2020)

Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic
por: McGoran, John, et al.
Publicado: (2021)

Reactivation of Chagas disease after autologous hematopoietic stem cell transplantation
por: Chalela, Claudia Marcela, et al.
Publicado: (2020)

Sarcoidosis secondary to lymphocyte active immunotherapy treated with infliximab
por: de Souza, Gabriela Higino, et al.
Publicado: (2018)

Lewis-Sumner syndrome associated with infliximab therapy for psoriasis
por: de Oliveira, Karen Fernandes, et al.
Publicado: (2017)

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2021)

Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease
por: Francisco, Amanda Fortes, et al.
Publicado: (2013)

Direct economic impact of Chagas disease treatment
por: Zaidel, Ezequiel J., et al.
Publicado: (2022)

Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
por: Romagnuolo, Maurizio, et al.
Publicado: (2022)

Chagas Disease in Ancient Hunter-Gatherer Population, Brazil
por: Lima, Valdirene S., et al.
Publicado: (2008)

Fragmented QRS and Chagas' disease
por: Baranchuk, Adrian
Publicado: (2014)

Symptomless Pulmonary Cryptococcosis in a Psoriatic Arthritis Patient during Infliximab Therapy
por: Yamada, Saori, et al.
Publicado: (2016)

Two Cases of Generalized Pustular Psoriasis: Successful Treatment with Infliximab
por: Kim, Hoon-Soo, et al.
Publicado: (2014)

Indeterminate Form of Chagas Disease: Some Immunological Insights
por: Matos, Daniel Mazza, et al.
Publicado: (2022)

Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014)

Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
por: Timper, Katharina, et al.
Publicado: (2013)

Physician Awareness of Chagas Disease, USA
por: Stimpert, Kelly K., et al.
Publicado: (2010)

Chagas Disease Infection Reactivation after Heart Transplant
por: Moreira, Maria da Consolação Vieira, et al.
Publicado: (2020)

Hospitalization for Chagas Heart Disease in the United States From 2002 to 2017
por: Lima, Neiberg de Alcantara, et al.
Publicado: (2021)

Heart Rate Variability and Chagas Heart Disease
por: Almeida-Santos, Marcos Antonio, et al.
Publicado: (2015)

Successful Treatment of Tolosa-Hunt Syndrome after a Single Infusion of Infliximab
por: Halabi, Tarek, et al.
Publicado: (2018)

Infliximab: A treatment option for multisystem inflammatory syndrome in children with ulcerative colitis?
por: Alkan, Gulsum, et al.
Publicado: (2021)

Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis
por: Trídico, Lívia Arroyo, et al.
Publicado: (2017)

Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab
por: Ohshima, Yuichiro, et al.
Publicado: (2013)

Infliximab treatment in a paediatric patient with ulcerative colitis, who developed acute pancreatitis due to azathioprine during follow-up
por: Basturk, Ahmet, et al.
Publicado: (2017)

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
por: Miranda, Carla Paixão, et al.
Publicado: (2014)

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
por: Ducourau, Emilie, et al.
Publicado: (2011)

Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
por: Kurizky, Patricia Shu, et al.
Publicado: (2019)

Response of Fibroblastic Rheumatism to Infliximab
por: Romiti, Ricardo, et al.
Publicado: (2009)

Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn’s Disease on Infliximab
por: Chow, Stephen, et al.
Publicado: (2016)

Henoch-Schönlein purpura associated with infliximab therapy for pediatric Crohn’s disease
por: Li, Xiaolu, et al.
Publicado: (2022)

Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
por: Bacsur, Péter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ds231nn6bn24ek45vm311p9s7k